Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
First Watch Restaurant Group
FWRG
$771M
| $367K | ﹤0.01% |
21,730
-1,429
| -6% | -$23.7K |
|
2827
Revolve Group
RVLV
$1.86B
| $367K | ﹤0.01% |
22,392
-73,746
| -77% | -$1.37M |
|
|
EVBN
2828
DELISTED
Evans Bancorp Inc
EVBN
| $366K | ﹤0.01% |
14,688
-951
| -6% | -$25.8K |
|
2829
Meridian
MRBK
$236M
| $366K | ﹤0.01% |
37,352
| – | – |
|
|
LICY
2830
DELISTED
Li-Cycle Holdings Corp.
LICY
| $366K | ﹤0.01% |
8,242
-5,767
| -41% | -$236K |
|
2831
Alerus Financial
ALRS
$853M
| $366K | ﹤0.01% |
20,346
-4,054
| -17% | -$65.7K |
|
2832
Vermilion Energy
VET
$1.76B
| $365K | ﹤0.01% |
29,296
+28,906
| +7,412% | +$356K |
|
2833
First Bank
FRBA
$471M
| $364K | ﹤0.01% |
35,093
-4,690
| -12% | -$47.8K |
|
2834
Sprott Physical Silver Trust
PSLV
$12B
| $363K | ﹤0.01% |
46,656
| – | – |
|
2835
SandRidge Energy
SD
$503M
| $363K | ﹤0.01% |
23,810
-6,056
| -20% | -$88.9K |
|
|
CVGW
2836
DELISTED
Calavo Growers
CVGW
| $362K | ﹤0.01% |
12,476
-5,426
| -30% | -$168K |
|
|
KREF
2837
KKR Real Estate Finance Trust
KREF
$465M
| $360K | ﹤0.01% |
29,556
-111
| -0.4% | -$1.25K |
|
2838
Relmada Therapeutics
RLMD
$556M
| $359K | ﹤0.01% |
145,999
+131,161
| +884% | +$363K |
|
2839
DXP Enterprises
DXPE
$2.53B
| $358K | ﹤0.01% |
9,829
+1,917
| +24% | +$57.9K |
|
|
TWKS
2840
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $358K | ﹤0.01% |
47,399
-28,531
| -38% | -$211K |
|
2841
AB InBev
BUD
$166B
| $358K | ﹤0.01% |
6,307
+4,489
| +247% | +$272K |
|
2842
Cass Information Systems
CASS
$722M
| $357K | ﹤0.01% |
9,205
-10,006
| -52% | -$393K |
|
2843
Alignment Healthcare
ALHC
$3.02B
| $356K | ﹤0.01% |
61,927
-620
| -1% | -$4.01K |
|
2844
iRadimed
IRMD
$1.17B
| $356K | ﹤0.01% |
7,453
-2,049
| -22% | -$92.4K |
|
|
CCF
2845
DELISTED
Chase Corporation
CCF
| $356K | ﹤0.01% |
2,935
-897
| -23% | -$103K |
|
2846
Gevo
GEVO
$355M
| $354K | ﹤0.01% |
232,957
-37,765
| -14% | -$48.8K |
|
|
CLPR
2847
Clipper Realty
CLPR
$44.4M
| $354K | ﹤0.01% |
62,371
-3,524
| -5% | -$19.2K |
|
2848
Xenon Pharmaceuticals
XENE
$6.02B
| $353K | ﹤0.01% |
9,179
+9,079
| +9,079% | +$361K |
|
2849
Bally's
BALY
$689M
| $353K | ﹤0.01% |
22,680
-5,771
| -20% | -$93.1K |
|
2850
Primoris Services
PRIM
$4.77B
| $353K | ﹤0.01% |
11,570
-43,383
| -79% | -$1.16M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.